Stockreport

LENZ Therapeutics GAAP EPS of -$1.16 misses by $0.26, revenue of $1.59M misses by $1.5M [Seeking Alpha]

LENZ Therapeutics, Inc.  (LENZ) 
PDF Cash, cash equivalents and marketable securities were $292.3 million as of December 31, 2025, which is anticipated to fund operations to post-launch positive operating [Read more]